Our client, a first commercial biotech, had a need for full commercialization support ahead of a new drug launch.
Shortly after launch, they encountered financial challenges which drove them to recommend ceasing commercialization support.
Provide strategic guidance on how to most effectively maintain a market presence while exploring additional financial options.
Proposed an “at risk” commercialization model due to our level of engagement with the brand.
Jointly developed an overall go-to-market strategy to maximize awareness.
Client was able to maintain a commercial presence for an additional 12 months post launch.
While Inizio Engage and the client decided against the “at risk” commercialization model, we now better understand the risk/reward profile and investment case to make commercialization a reality.
